Remembering 2025 Milestones | Vytrus Biotech

News
January 20, 2026

2025 has been a landmark year for Vytrus Biotech, marked by scientific breakthroughs, global recognition, strong commercial performance and a deeper integration of sustainability and corporate governance. From pioneering science and award-winning innovations to record financial results and international scientific outreach, this year set new benchmarks in our journey as a global leader in cosmetic biotechnology.

 

Clarivine™ – Fasting for Skin Longevity

In April 2025, Vytrus launched Clarivine™, a novel bioinspired active that mimics the cellular benefits of fasting to improve skin longevity, texture, tone and radiance. Clarivine™ delivers visible “glass skin” effects supported by clinical validation and was introduced on the global stage at in-cosmetics Global 2025.

 

Awards

Vytrus’ innovations received significant industry recognition throughout the year:

  • Clarivine™ was awarded Best Ingredient Award at in-cosmetics Global 2025, highlighting its disruptive scientific approach and innovation.
  • Clarivine™ also earned a major Innovation Award at ICI Indonesia 2025, expanding its recognition across global markets.
  • Two additional Vytrus ingredients featuring natural plant exosomes (Centella Reversa™ and Capilia Longa™) received honours at the BSB Innovation Awards 2025, a benchmark in Europe.
  • BIOADAPT, Vytrus’ adaptive formulation concept, was recognised with 1st Prize for Formulation at Cosmetorium 2025, underscoring innovation in sustainable and modular cosmetic design.

 

About Bioadapt

BIOADAPT stood out in 2025 as a flagship concept in adaptive skincare, combining scientific rigour with formulation versatility. Its award at Cosmetorium 2025 confirmed its relevance as a next-generation approach in customized cosmetic solutions.

 

Key Scientific Milestones 2025 | Vytrus Biotech

2025 reinforced our role as a reference in cosmetic biotechnology and scientific knowledge dissemination:

🔬 Podium presentation at IFSCC Cannes 2025
Vytrus was selected as a Top 10 Best Applied Research finalist at the 35th IFSCC Congress in Cannes. Our research on a novel bioinspired self-delivery mechanism based on transient membrane pores was presented by Dr. Òscar Expósito, CEO, CSO and co-founder, and recognised among the highest honours in global cosmetic science.

📖 Publication in IFSCC Magazine
Our advanced research in plant peptidomics and proteomics was published in IFSCC Magazine (Vol. 27, No. 4) — a testament to our cutting-edge approach to skin and hair regeneration, following its prior selection among the Top 10 Posters at IFSCC 2024.

🧪 IFSCC Scientific Webinar
Vytrus hosted an official IFSCC webinar, “Following Nature’s Rules: A Step Forward in Skin and Hair Care through Advanced Plant Peptidomics and Proteomics”, led by Dr. Expósito, further solidifying our commitment to scientific education and industry knowledge sharing.

🎥 Scientific Reels Capsule
We launched a series of educational scientific reels designed to translate complex biotechnological concepts into accessible formats for the wider industry and community in our  .

 

Exosomes – Plant Nanostructures for Performance

Vytrus continued to advance and communicate its leadership in natural plant exosomes, an emergent platform with high potential for regenerative and delivery applications in dermocosmetics and haircare. Exosomic Peptides technologies have been key drivers of growth in 2025.

 

Patents and Intellectual Property

Innovation in 2025 was underpinned by strengthened intellectual property protection:

  • The United States Patent Office granted a patent covering applications related to skin re-youth and wound healing, reinforcing our proprietary technological base.
  • Our portfolio of patented technologies associated with plant exosomes and high-performance bioactives further differentiates our scientific platform in the global marketplace.

 

Fairs & Global Presence

Vytrus marked its presence at the world’s most strategic industry events. Among others, we visited:

  • in-cosmetics Global 2025 – global launch and award recognition for Clarivine™.
  • IFSCC 35th World Congress (Cannes) – podium presentation and scientific visibility.
  • Cosmetorium 2025 – BIOADAPT awarded among top formulations.

And many more fairs in France, Korea, Thailand, Brazil, Italy and worldwide!

 

ESG — Environmental, Social and Governance Milestones

In 2025 Vytrus intensified its ESG commitment:

  • Renewed EcoVadis Platinum Medal, positioning the company within the top 1% of global organisations assessed for sustainability performance.
  • Publication of the 2024 Sustainability Report with updated key indicators and expanded carbon footprint analysis.
  • Presentation of the first Progress Report (CoP) to the United Nations Global Compact, reaffirming alignment with universal principles and the Sustainable Development Goals (SDGs).
  • Initiation of a transformation cultural and governance strategy to embed sustainability deeply across the organisation.

 

Commercial & Financial Highlights

2025 was also a record year for business performance:

  • Record first-half performance: Vytrus achieved €4.38M in revenues, a +75% increase year-on-year, with EBITDA rising +111% and net profit growing +182%.
  • The company expanded commercial direct sales in Spain and France, reinforcing proximity with key partners and accelerating growth.
  • Growth was robust across all geographies, with strong double-digit increases in Europe, the Americas and Asia-Pacific markets.

 

2025 reaffirmed Vytrus’ purpose: combining science, sustainability and innovation to transform the future of cosmetic biotechnology. We look forward to continuing this trajectory in the years ahead!